At least twice in interviews or conference calls,

Quote:

---

At least twice in interviews or conference calls, Pourhassan has explained that Cytodyn requested to use leronlimab on covid patients way back in March and the FDA said "No, you have to do some preclinical studies."

---

Which just goes to show the abject stupidity of the FDA. I figured out the MOA on January 11th for pulmonary inflammation in influenza. They must have bureaucrats with no scientific background making these decisions.